These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 25804062)
1. Synthetic amphibian peptides and short amino-acids derivatives against planktonic cells and mature biofilm of Providencia stuartii clinical strains. Ostrowska K; Kamysz W; Dawgul M; Różalski A Pol J Microbiol; 2014; 63(4):423-31. PubMed ID: 25804062 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptides as potential tool to fight bacterial biofilm. Dawgul M; Maciejewska M; Jaskiewicz M; Karafova A; Kamysz W Acta Pol Pharm; 2014; 71(1):39-47. PubMed ID: 24779193 [TBL] [Abstract][Full Text] [Related]
3. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474 [TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin]. Kotulová D; Slobodníková L Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536 [TBL] [Abstract][Full Text] [Related]
6. High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis. Liu Y; Knapp KM; Yang L; Molin S; Franzyk H; Folkesson A Int J Antimicrob Agents; 2013 Jan; 41(1):20-7. PubMed ID: 23153961 [TBL] [Abstract][Full Text] [Related]
7. Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. Stock I; Wiedemann B J Med Microbiol; 1998 Jul; 47(7):629-42. PubMed ID: 9839568 [TBL] [Abstract][Full Text] [Related]
8. Biofilm eradication kinetics of the ultrashort lipopeptide C12 -OOWW-NH2 utilizing a modified MBEC Assay(™). Laverty G; Gorman SP; Gilmore BF Chem Biol Drug Des; 2015 May; 85(5):645-52. PubMed ID: 25264285 [TBL] [Abstract][Full Text] [Related]
9. Providencia stuartii form biofilms and floating communities of cells that display high resistance to environmental insults. El Khatib M; Tran QT; Nasrallah C; Lopes J; Bolla JM; Vivaudou M; Pagès JM; Colletier JP PLoS One; 2017; 12(3):e0174213. PubMed ID: 28334028 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Proteus mirabilis distribution in multi-species biofilms on urinary catheters and determination of bacteria resistance to antimicrobial agents. Moryl M; Torzewska A; Jałmuzna P; Rózalski A Pol J Microbiol; 2013; 62(4):377-84. PubMed ID: 24730132 [TBL] [Abstract][Full Text] [Related]
11. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. Tumbarello M; Citton R; Spanu T; Sanguinetti M; Romano L; Fadda G; Cauda R J Antimicrob Chemother; 2004 Feb; 53(2):277-82. PubMed ID: 14688041 [TBL] [Abstract][Full Text] [Related]
13. Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia. Barl P; Bedenić B; Sardelić S; Uzunović S; Vraneš J; Plečko V Med Glas (Zenica); 2012 Aug; 9(2):317-24. PubMed ID: 22926370 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci. da Silva BR; de Freitas VA; Carneiro VA; Arruda FV; Lorenzón EN; de Aguiar AS; Cilli EM; Cavada BS; Teixeira EH Peptides; 2013 Apr; 42():78-83. PubMed ID: 23340019 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii. Jaśkiewicz M; Neubauer D; Kazor K; Bartoszewska S; Kamysz W Probiotics Antimicrob Proteins; 2019 Mar; 11(1):317-324. PubMed ID: 30043322 [TBL] [Abstract][Full Text] [Related]
17. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Almaaytah A; Mohammed GK; Abualhaijaa A; Al-Balas Q Drug Des Devel Ther; 2017; 11():3159-3170. PubMed ID: 29138537 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of plasmid-mediated quinolone resistance-qnrA1 and blaVEB-1 gene in a Providencia stuartii strain. Nazik H; Bektöre B; Öngen B; Özyurt M; Baylan O; Haznedaroğlu T New Microbiol; 2011 Apr; 34(2):225-8. PubMed ID: 21617836 [TBL] [Abstract][Full Text] [Related]
19. New derivatives of dehydroabietic acid target planktonic and biofilm bacteria in Staphylococcus aureus and effectively disrupt bacterial membrane integrity. Manner S; Vahermo M; Skogman ME; Krogerus S; Vuorela PM; Yli-Kauhaluoma J; Fallarero A; Moreira VM Eur J Med Chem; 2015 Sep; 102():68-79. PubMed ID: 26241878 [TBL] [Abstract][Full Text] [Related]